Maxsyara Felismino da Silva Soares
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maxsyara Felismino da Silva Soares has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Maria Fernandes de Oliveira
Psychopharmacology Laboratory, Institute for Drug and Medicine Research, Federal University of Paraíba, João Pessoa 58051-900, PB, Brazil
1 shared publication - Alissa Maria de Oliveira Martins
Psychopharmacology Laboratory, Institute for Drug and Medicine Research, Federal University of Paraíba, João Pessoa 58051-900, PB, Brazil
1 shared publication - André Luiz Leocádio de Souza Matos
Psychopharmacology Laboratory, Institute for Drug and Medicine Research, Federal University of Paraíba, João Pessoa 58051-900, PB, Brazil
1 shared publication - Cícero Francisco Bezerra Felipe
Psychopharmacology Laboratory, Institute of Drugs and Medicines Research, Federal University of Paraíba, João Pessoa 58051-900, PB, Brazil
1 shared publication - Lucas Nóbrega de Oliveira
Psychopharmacology Laboratory, Institute for Drug and Medicine Research, Federal University of Paraíba, João Pessoa 58051-900, PB, Brazil
1 shared publication - Luciana Scotti
Postgraduate Program in Natural Synthetic and Bioactive Products, Health Sciences Center, Federal University of Paraíba, João Pessoa 58051-900, PB, Brazil, Brazil
1 shared publication
Latest Publications
- Open Access
- 10 July 2026
- Published by MDPI AG in Journal of Xenobiotics
- Vol. 16 (4) , 129
From Xenobiotic Exposure to Neuroinflammation: Mechanisms Linking Lipopolysaccharide Signaling to Depressive-like Behavior
Depression is increasingly recognized as a multifactorial disorder involving immune, metabolic, and neurobiological disturbances that extend beyond classical monoaminergic hypotheses. Among xenobiotic-based experimental approaches, lipopolysaccharide (LPS) has become a valuable tool for investigating how peripheral inflammatory stimuli are translated into central neurobiological dysfunction. This narrative review aimed to integrate current evidence regarding the mechanisms by which LPS-induced neuroimmune activation contributes to depression-related phenotypes and to discuss the translational relevance of these findings. Literature searches were performed in PubMed, ScienceDirect, and Google Scholar, focusing on studies addressing inflammatory signaling, oxidative imbalance, inflammasome activation, neurotransmitter dysfunction, and experimental modeling strategies. Current evidence suggests that LPS-induced neuroinflammation involves a dynamic interaction between peripheral immune signaling, mitochondrial dysfunction, redox imbalance, and glial activation, establishing self-amplifying mechanisms capable of sustaining chronic inflammatory states. Such alterations profoundly affect kynurenine metabolism, glutamatergic homeostasis, and reward-related neurotransmission, thereby contributing to synaptic dysfunction and behavioral impairment. Experimental findings obtained from animal, cellular, and computational platforms further support the emergence of integrated therapeutic strategies targeting multiple neuroimmune pathways. Collectively, these observations reinforce the concept that neuroinflammation represents a central biological interface linking xenobiotic exposure to depressive-like behavior.
- 10 July 2026
- Published by MDPI AG in Journal of Xenobiotics
- Vol. 16 (4) , 129
Open AccessFrom Xenobiotic Exposure to Neuroinflammation: Mechanisms Linking Lipopolysaccharide Signaling to Depressive-like Behavior
Depression is increasingly recognized as a multifactorial disorder involving immune, metabolic, and neurobiological disturbances that extend beyond classical monoaminergic hypotheses. Among xenobiotic-based experimental approaches, lipopolysaccharide (LPS) has become a valuable tool for investigating how peripheral inflammatory stimuli are translated into central neurobiological dysfunction. This narrative review aimed to integrate current evidence regarding the mechanisms by which LPS-induced neuroimmune activation contributes to depression-related phenotypes and to discuss the translational relevance of these findings. Literature searches were performed in PubMed, ScienceDirect, and Google Scholar, focusing on studies addressing inflammatory signaling, oxidative imbalance, inflammasome activation, neurotransmitter dysfunction, and experimental modeling strategies. Current evidence suggests that LPS-induced neuroinflammation involves a dynamic interaction between peripheral immune signaling, mitochondrial dysfunction, redox imbalance, and glial activation, establishing self-amplifying mechanisms capable of sustaining chronic inflammatory states. Such alterations profoundly affect kynurenine metabolism, glutamatergic homeostasis, and reward-related neurotransmission, thereby contributing to synaptic dysfunction and behavioral impairment. Experimental findings obtained from animal, cellular, and computational platforms further support the emergence of integrated therapeutic strategies targeting multiple neuroimmune pathways. Collectively, these observations reinforce the concept that neuroinflammation represents a central biological interface linking xenobiotic exposure to depressive-like behavior.